Researchers analyzed 99 patient samples and identified patterns of gene activity strongly associated with oestrogen receptor status and tumour grade. These findings may help characterize tumours more effectively and predict patient outcomes, including survival rates and relapse risk.
ColorBrewer is a free web-based tool that enables users to select from various color schemes for their maps. The tool offers sequential, diverging, and qualitative schemes, allowing users to test and refine their choices. Additionally, ColorBrewer provides detailed color specifications for printing, projection, or web display.
Researchers have discovered four biochemical markers that can predict a woman's likelihood of developing metastatic disease in node-negative breast cancer. These markers, including p53, E-cadherin, and nm23H1, were found to be significant predictors of outcome, allowing for more accurate identification of patients at risk. This breakth...
The new center will explore various initiatives toward insulin independence without long-term immunosuppression. Researchers will investigate less toxic drugs and test donor islets protected by a sheath-like membrane to reduce immune response.
A recent study found that postpartum fatigue is significantly linked to postpartum depression, with women reporting symptoms after just 28 days, highlighting the need for screening tools and self-care support
A large study of Norwegian and Swedish women found that using oral contraceptives may increase the risk of developing breast cancer, particularly when used later in reproductive life. The risk was highest among women aged 45 or over who were still taking the pill.
A study found that elderly patients' sense of caring, technical proficiency, and office environment are key factors in meeting their medical care expectations. Physicians who connect personally with patients, spend time with them, and demonstrate competence can earn high marks for caring.
Younger women with Hodgkin's Disease are at a higher risk of developing breast cancer after radiotherapy, particularly if they have a family history or underwent splenectomy. Modern treatment methods aim to lower this increased risk.
Researchers have developed new markers capable of detecting minute numbers of cancer cells in blood, using three genes shown to be over-expressed in invasive breast cancer. The markers' sensitivity and specificity are greatly enhanced when used in combination.